CASP3 and cancer: Decreases PI 3K/Akt expression, promotes Bad activation, decreases Bcl-xl, and increases cyto-c release, leading to caspase-9 and caspase-3 activation, PARP cleavage, and apoptosis. Increased levels of SCFAs led to apoptosis of cancer cells in vitro.